$Limelight Networks (LLNW.US)$
go go

Love it! @moomoo Rewards

$富途控股 (FUTU.US)$ 開始！

$美國超微公司 (AMD.US)$ it will go back to $150 by tomo and hit $200 by year end. i believed in Lisa Su !! She will bring AMD to higher level in the meta space!

$Limelight Networks (LLNW.US)$
🦖

$富途控股 (FUTU.US)$ 上涨至大约53美元..因为看好的时机即将开始..下周四之前达到70美元。然后周五回落..然后再过一周之后又出现牛市..我的想法。

$富途控股 (FUTU.US)$ $向上融科 (TIGR.US)$
Ladies and gentlemen, it is your friendly neighbourhood 股神 again.
After much debate and discussion on both fundamental and technical analysis, as well as brokerage and security laws with my fellow investment friends, we have collectively came to the same conclusion - these 2 stocks have indeed reached rock bottom and can only rise from here.
Some conclusions:
1. China is easing up on its regulatory grip. Refer to recent news and Biden-Xi virtual meeting discussion.
2. The fear of regulation has already been priced into both stocks.
3. 2 Possible regulatory outcomes:
A) Both companies be slapped with a fine, comply with regulations and funding limits for mainland customers onto the platforms will be imposed. (Most likely)
B) The worse that can happen is a complete ban - no new mainland customers can be acquired, but existing customers with funds already overseas is out of grip. Also, savvy investors will still be able to transfer their money overseas via various means.
To conclude, we expect both stocks to rise soon, with TIGR going up much more. We welcome you to join us on board of this train.
有危机，才有商机。
Have fun investing. Cheers!!

$Skillz (SKLZ.US)$ 富貴險中求，CEO換了是否暴漲一次

Shares of $輝瑞 (PFE.US)$ closed today at $50.87, an all-time high.
The drugmaker's previous all-time high, $50.42, was reached on Aug. 17, 2021.
Pfizer benefitted today from a number of catalysts. Barclays analysts provided a bullish forecast on potential sales of its COVID-19 antiviral Paxlovid next year.
In addition, the Biden administration said it would invest billions to boost production of COVID-19 vaccines -- singling out mRNA shots -- to increase access in poorer nations.
Pfizer could see additional upside in the coming days as the FDA may authorize boosters of its COVID-19 shot for all adults as soon as tomorrow, and a CDC advisory panel will weigh those shots in this population on Friday.

$富途控股 (FUTU.US)$ 開市衝上去，已超賣